Evolva Holding SA
SIX:EVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Walmart Inc
LSE:0R1W
|
US |
Evolva Holding SA
Research & Development
Evolva Holding SA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Evolva Holding SA
SIX:EVE
|
Research & Development
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sika AG
F:SIKA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Givaudan SA
SIX:GIVN
|
Research & Development
-CHf522m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evolva Holding SA
Glance View
Evolva Holding SA is a biotech company, which engages in the research, development, manufacture, and commercialization of nutritional, healthcare, and wellness ingredients. The company is headquartered in Reinach, Basel-Landschaft and currently employs 68 full-time employees. The company went IPO on 2005-05-04. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The firm is focused on developing and increase the yield and efficiency of the production of various ingredients.
See Also
What is Evolva Holding SA's Research & Development?
Research & Development
0
CHF
Based on the financial report for Jun 30, 2025, Evolva Holding SA's Research & Development amounts to 0 CHF.